Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Karl J. Jankowski is active.

Publication


Featured researches published by Karl J. Jankowski.


International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology | 1991

The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates

Alice Harrison; Carole Walker; David Parker; Karl J. Jankowski; Jonathan P. L. Cox; Andrew S. Craig; J.M. Sansom; Nigel Robert Arnold Beeley; R.A. Boyce; L. Chaplin; Michael Anthony William Eaton; A.P.H. Farnsworth; Kenneth Millar; Andrew T. Millican; Amanda M. Randall; Stephen Keith Rhind; D.S. Secher; A. Turner

Yttrium binding ligands DOTA, caDTPA and CT-DTPA were each conjugated to monoclonal antibody B72.3, labelled with 90Y and injected into mice in order to assess the in vivo inertness of the antibody-linked 90Y-ligand complexes. Levels of 90Y in femur shafts of the DOTA-B72.3 mice were low, being approximately 7 and 44%, respectively, of levels in the femur shafts of the caDTPA-B72.3 and CT-DTPA-B72.3 treated mice. This finding demonstrates the greater inertness and by implication the greater suitability for immunotherapy of the DOTA-90Y complex.


Journal of The Chemical Society, Chemical Communications | 1989

Synthesis of a kinetically stable yttrium-90 labelled macrocycle–antibody conjugate

Jonathan P. L. Cox; Karl J. Jankowski; Ritu Kataky; David Parker; Nigel Robert Arnold Beeley; Byron A. Boyce; Michael Anthony William Eaton; Kenneth Millar; Andrew T. Millican; Alice Harrison; Carole Walker

Lysine is a precursor for the synthesis of an aminobutyl C-functionalised tetra-azacyclododecane tetra-acid which has been linked to B72.3 antibody and may be labelled with 90Y to form a kinetically stable complex of potential use in radioimmunotherapy.


Journal of The Chemical Society, Chemical Communications | 1989

Towards tumour imaging with indium-111 labelled macrocycle–antibody conjugates

Andrew S. Craig; Ian M. Helps; Karl J. Jankowski; David Parker; Nigel Robert Arnold Beeley; Byron A. Boyce; Michael Anthony William Eaton; Andrew T. Millican; Kenneth Millar; Alison Phipps; Stephen Keith Rhind; Alice Harrison; Carole Walker

C-Functionalised triazacyclododecane and triazacyclononane triacid macrocycles have been covalently attached to a monoclonal antibody and may be labelled with 111In to form kinetically inert radiolabelled complexes.


Pure and Applied Chemistry | 1989

Implementation of macrocycle conjugated antibodies for tumour-targetting

David Parker; J. R. Morphy; Karl J. Jankowski; Jonathan P. L. Cox

Monoclonal antibodies may be selectively functionalised with macrocyclic ligands, permitting the transport of an imaging or c totoxic metal radionuclide specifically to a tumour. Antibodies conju ated to p13) and (14)-membered tetraazamacrocycles allow 64Cu or 67Cu labefled antibody to be used for imaging or therapy.


Journal of The Chemical Society-perkin Transactions 1 | 1990

Synthesis of C- and N-functionalised derivatives of 1,4,7-triazacyclononane-1,4,7-triyltriacetic acid (NOTA), 1,4,7,10-tetra-azacyclododecane-1,4,7,10-tetrayltetra-acetic acid (DOTA), and diethylenenetriaminepenta-acetic acid (DTPA): bifunctional complexing agents for the derivatisation of antibodies

Jonathan P. L. Cox; Andrew S. Craig; Ian M. Helps; Karl J. Jankowski; David Parker; Michael Anthony William Eaton; Andrew T. Millican; Kenneth Millar; Nigel Robert Arnold Beeley; Byron A. Boyce

Using (2S)-lysine as a precursor, the syntheses of aminobutyl derivatives of 1,4,7-triazacyclononane, 1,4,7,10-tetra-azacyclododecane, and 3-azapentane-1,5-diamine are described. Transformation into their reactive maleimide derivatives is described and alternative strategies for synthesising the title complexing agents involving nitrogen functionalisation are defined.


Journal of The Chemical Society, Chemical Communications | 1990

Synthesis and complexation behaviour of an effective octadentate complexone 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis[methylene(methylphosphinic acid)]

Christopher J. Broan; Karl J. Jankowski; Ritu Kataky; David Parker; Amanda M. Randall; Alice Harrison

The title ligand and a C-functionalised analogue have been prepared; the ligand is very strongly basic [pKa LH+, LH2+ < 14 (298 K)] and forms remarkably stable complexes with yttrium and calcium.


Journal of The Chemical Society, Chemical Communications | 1990

Synthesis and complex stability of parent and C-functionalised derivatives of 1,4,7-triazacyclononane-1,4,7-tris[methylene(methylphosphinic acid)]: an effective new complexing agent

Christopher J. Broan; Karl J. Jankowski; Ritu Kataky; David Parker

The title ligand forms kinetically stable complexes with indium and gallium and exhibits a marked selectivity (105.6) for binding Mg2+ over Ca2+ in aqueous solution.


Journal of The Chemical Society-perkin Transactions 1 | 1989

Syntheses of C- and N-functionalised derivatives of 1,5,9-triazacyclododecane

Ian M. Helps; David Parker; Karl J. Jankowski; James Chapman; Patrick E. Nicholson

The synthesis of a series of di- and tri-N-substituted triazacyclododecane ligands has been effected through the intermediary of monotosylamide derivatives. A C-functionalised aminobenzyl [12]-N3 tris(carboxymethyl) derivative has been prepared permitting subsequent linkage to a protein.


Journal of The Chemical Society-perkin Transactions 1 | 1989

Studies related to penicillins. Part 28. β-Elimination reactions of sulphones derived from penicillins leading to cis-3-acylamino-4-oxoazetidine-2-sulphinic acids

G. D. Sriyani Ananada; Karl J. Jankowski; Anthony Schofield; John Steele; Richard J. Stoodley; Colin W. Greengrass

The reactions of the 3-acetyl and 3-formyl derivatives of (3S,5R,6R)-2,2-dimethyl-6-phenoxyacetamidopenam 1,1-dioxide, i.e. compounds (5e,f), and of p-nitrophenyl (3S,5R,6R)benzylpenicillinate 1,1-dioxide (1f) with 1,5-diazabicyclo[5.3.0]non-5-ene (DBN) followed by iodomethane have been studied. In the case of penam dioxide (5e), epimerisation at position 6 competes with the β-elimination at position 3 and a mixture of the trans- and cis-azetidinones (11a) and (12a) is isolated. No epimerisation is observed with compounds (5f) and (1f), which react to give the corresponding cis-azetidinones (12b,c). It is possible to avoid the epimerisation of the penam dioxide (5e), and to isolate the cis-azetidinesulphinate salt (13), by using potassium t-butoxide in place of DBN. The cis-azetidinesulphinic acid (8c) is also isolable from the reaction of the penicillinate dioxide (1f) with DBN followed by acidic work-up. It undergoes O-methylation of the sulphinic acid group in the presence of diazomethane to give the methyl sulphinate (19), as a mixture of diastereoisomers. Saponification of the p-nitrophenyl ester of the cis-azetidinesulphinic acid (8c) is effected by sodium hydroxide to give the disodium salt (18b), which undergoes methylation in the presence of iodomethane to afford the dimethyl derivative (12d).


Synthesis | 1992

Synthesis of new macroclyclic amino-phosphinic acid complexing agents and their C- and P-functionalised derivaties for protein linkage

Christopher J. Broan; Eleanor Cole; Karl J. Jankowski; David Parker; Kanthi Pulukkody; Byron A. Boyce; Nigel Robert Arnold Beeley; Kenneth Millar; Andrew T. Millican

Collaboration


Dive into the Karl J. Jankowski's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carole Walker

Medical Research Council

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge